{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T21:49:37Z","timestamp":1787003377791,"version":"build-2736575974"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,10,8]],"date-time":"2018-10-08T00:00:00Z","timestamp":1538956800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,10,8]],"date-time":"2018-10-08T00:00:00Z","timestamp":1538956800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>BMP4\/7-dependent expression of inhibitor of differentiation\/DNA binding (Id) proteins 1 and 3 has been implicated in tumor progression and poor prognosis of malignant melanoma patients. Hyaluronic acid (HA), a pericellular matrix component, supports BMP7 signalling in murine chondrocytes through its receptor CD44. However, its role in regulating BMP signalling in melanoma is not clear. In this study we found that depletion of endogenously-produced HA by hyaluronidase treatment or by inhibition of HA synthesis by 4-methylumbelliferone (4-MU) resulted in reduced BMP4\/7-dependent Id1\/3 protein expression in mouse melanoma B16-F10 and Ret cells. Conversely, exogenous HA treatment increased BMP4\/7-dependent Id1\/3 protein expression. Knockdown of CD44 reduced BMP4\/7-dependent Id1\/3 protein expression, and attenuated the ability of exogenous HA to stimulate Id1 and Id3 expression in response to BMP. Co-IP experiments demonstrated that CD44 can physically associate with the BMP type II receptor (BMPR) ACVR2B. Importantly, we found that coordinate expression of Id1 or Id3 with HA synthases HAS2, HAS3, and CD44 is associated with reduced overall survival of cutaneous melanoma patients. Our results suggest that HA-CD44 interactions with BMPR promote BMP4\/7-dependent Id1\/3 protein expression in melanoma, contributing to reduced survival in melanoma patients.<\/jats:p>","DOI":"10.1038\/s41598-018-33337-7","type":"journal-article","created":{"date-parts":[[2018,10,2]],"date-time":"2018-10-02T05:46:34Z","timestamp":1538459194000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Hyaluronic acid-CD44 interactions promote BMP4\/7-dependent Id1\/3 expression in melanoma cells"],"prefix":"10.1038","volume":"8","author":[{"given":"Ruo-Lin","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georg","family":"Sedlmeier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lenka","family":"Kyjacova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anja","family":"Schmaus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Philipp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wilko","family":"Thiele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0013-9064","authenticated-orcid":false,"given":"Boyan K.","family":"Garvalov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1718-7687","authenticated-orcid":false,"given":"Jonathan P.","family":"Sleeman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,10,8]]},"reference":[{"key":"33337_CR1","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1042\/BST20160263","volume":"45","author":"G Sedlmeier","year":"2017","unstructured":"Sedlmeier, G. & Sleeman, J. P. Extracellular regulation of BMP signaling: welcome to the matrix. Biochem Soc Trans 45, 173\u2013181, https:\/\/doi.org\/10.1042\/BST20160263 (2017).","journal-title":"Biochem Soc Trans"},{"key":"33337_CR2","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/0092-8674(90)90214-Y","volume":"61","author":"R Benezra","year":"1990","unstructured":"Benezra, R., Davis, R. L., Lockshon, D., Turner, D. L. & Weintraub, H. The protein Id: a negative regulator of helix-loop-helix DNA binding proteins. Cell 61, 49\u201359 (1990).","journal-title":"Cell"},{"key":"33337_CR3","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1016\/S0962-8924(03)00147-8","volume":"13","author":"MB Ruzinova","year":"2003","unstructured":"Ruzinova, M. B. & Benezra, R. Id proteins in development, cell cycle and cancer. Trends Cell Biol 13, 410\u2013418 (2003).","journal-title":"Trends Cell Biol"},{"key":"33337_CR4","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1038\/nrc3638","volume":"14","author":"A Lasorella","year":"2014","unstructured":"Lasorella, A., Benezra, R. & Iavarone, A. The ID proteins: master regulators of cancer stem cells and tumour aggressiveness. Nat Rev Cancer 14, 77\u201391, https:\/\/doi.org\/10.1038\/nrc3638 (2014).","journal-title":"Nat Rev Cancer"},{"key":"33337_CR5","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1016\/j.ccr.2010.10.023","volume":"18","author":"J Anido","year":"2010","unstructured":"Anido, J. et al. TGF-beta Receptor Inhibitors Target the CD44(high)\/Id1(high) Glioma-Initiating Cell Population in Human Glioblastoma. Cancer Cell 18, 655\u2013668, https:\/\/doi.org\/10.1016\/j.ccr.2010.10.023 (2010).","journal-title":"Cancer Cell"},{"key":"33337_CR6","doi-asserted-by":"publisher","first-page":"19506","DOI":"10.1073\/pnas.0709185104","volume":"104","author":"GP Gupta","year":"2007","unstructured":"Gupta, G. P. et al. ID genes mediate tumor reinitiation during breast cancer lung metastasis. Proc Natl Acad Sci USA 104, 19506\u201319511, https:\/\/doi.org\/10.1073\/pnas.0709185104 (2007).","journal-title":"Proc Natl Acad Sci USA"},{"key":"33337_CR7","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1172\/JCI63811","volume":"123","author":"F Niola","year":"2013","unstructured":"Niola, F. et al. Mesenchymal high-grade glioma is maintained by the ID-RAP1 axis. J Clin Invest 123, 405\u2013417, https:\/\/doi.org\/10.1172\/JCI63811 (2013).","journal-title":"J Clin Invest"},{"key":"33337_CR8","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1016\/j.ccr.2012.04.036","volume":"21","author":"CA O\u2019Brien","year":"2012","unstructured":"O\u2019Brien, C. A. et al. ID1 and ID3 regulate the self-renewal capacity of human colon cancer-initiating cells through p21. Cancer Cell 21, 777\u2013792, https:\/\/doi.org\/10.1016\/j.ccr.2012.04.036 (2012).","journal-title":"Cancer Cell"},{"key":"33337_CR9","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1038\/44334","volume":"401","author":"D Lyden","year":"1999","unstructured":"Lyden, D. et al. Id1 and Id3 are required for neurogenesis, angiogenesis and vascularization of tumour xenografts. Nature 401, 670\u2013677, https:\/\/doi.org\/10.1038\/44334 (1999).","journal-title":"Nature"},{"key":"33337_CR10","doi-asserted-by":"publisher","first-page":"78206","DOI":"10.18632\/oncotarget.12151","volume":"7","author":"L Zhang","year":"2016","unstructured":"Zhang, L. et al. BMP signaling and its paradoxical effects in tumorigenesis and dissemination. Oncotarget 7, 78206\u201378218, https:\/\/doi.org\/10.18632\/oncotarget.12151 (2016).","journal-title":"Oncotarget"},{"key":"33337_CR11","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1007\/s004320050342","volume":"126","author":"JH Clement","year":"2000","unstructured":"Clement, J. H. et al. Bone morphogenetic protein 2 (BMP-2) induces sequential changes of Id gene expression in the breast cancer cell line MCF-7. J Cancer Res Clin Oncol 126, 271\u2013279 (2000).","journal-title":"J Cancer Res Clin Oncol"},{"key":"33337_CR12","doi-asserted-by":"publisher","first-page":"4241","DOI":"10.1128\/MCB.24.10.4241-4254.2004","volume":"24","author":"M Kowanetz","year":"2004","unstructured":"Kowanetz, M., Valcourt, U., Bergstrom, R., Heldin, C. H. & Moustakas, A. Id2 and Id3 define the potency of cell proliferation and differentiation responses to transforming growth factor beta and bone morphogenetic protein. Mol Cell Biol 24, 4241\u20134254 (2004).","journal-title":"Mol Cell Biol"},{"key":"33337_CR13","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1038\/sj.onc.1209110","volume":"25","author":"EM Langenfeld","year":"2006","unstructured":"Langenfeld, E. M., Kong, Y. & Langenfeld, J. Bone morphogenetic protein 2 stimulation of tumor growth involves the activation of Smad-1\/5. Oncogene 25, 685\u2013692, https:\/\/doi.org\/10.1038\/sj.onc.1209110 (2006).","journal-title":"Oncogene"},{"key":"33337_CR14","doi-asserted-by":"publisher","first-page":"111","DOI":"10.3233\/CBM-2007-3205","volume":"3","author":"T Rothhammer","year":"2007","unstructured":"Rothhammer, T. et al. Bone morphogenetic protein 7 (BMP7) expression is a potential novel prognostic marker for recurrence in patients with primary melanoma. Cancer Biomark 3, 111\u2013117 (2007).","journal-title":"Cancer Biomark"},{"key":"33337_CR15","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1158\/0008-5472.448.65.2","volume":"65","author":"T Rothhammer","year":"2005","unstructured":"Rothhammer, T. et al. Bone morphogenic proteins are overexpressed in malignant melanoma and promote cell invasion and migration. Cancer Res 65, 448\u2013456 (2005).","journal-title":"Cancer Res"},{"key":"33337_CR16","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1038\/sj.bjc.6602792","volume":"93","author":"O Straume","year":"2005","unstructured":"Straume, O. & Akslen, L. A. Strong expression of ID1 protein is associated with decreased survival, increased expression of ephrin-A1\/EPHA2, and reduced thrombospondin-1 in malignant melanoma. Br J Cancer 93, 933\u2013938, https:\/\/doi.org\/10.1038\/sj.bjc.6602792 (2005).","journal-title":"Br J Cancer"},{"key":"33337_CR17","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1093\/carcin\/bgt479","volume":"35","author":"KA DiVito","year":"2014","unstructured":"DiVito, K. A., Simbulan-Rosenthal, C. M., Chen, Y. S., Trabosh, V. A. & Rosenthal, D. S. Id2, Id3 and Id4 overcome a Smad7-mediated block in tumorigenesis, generating TGF-beta-independent melanoma. Carcinogenesis 35, 951\u2013958, https:\/\/doi.org\/10.1093\/carcin\/bgt479 (2014).","journal-title":"Carcinogenesis"},{"key":"33337_CR18","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1083\/jcb.200402138","volume":"166","author":"RS Peterson","year":"2004","unstructured":"Peterson, R. S. et al. CD44 modulates Smad1 activation in the BMP-7 signaling pathway. J Cell Biol 166, 1081\u20131091, https:\/\/doi.org\/10.1083\/jcb.200402138 (2004).","journal-title":"J Cell Biol"},{"key":"33337_CR19","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1007\/s10555-014-9532-2","volume":"33","author":"A Schmaus","year":"2014","unstructured":"Schmaus, A., Bauer, J. & Sleeman, J. P. Sugars in the microenvironment: the sticky problem of HA turnover in tumors. Cancer Metastasis Rev 33, 1059\u20131079, https:\/\/doi.org\/10.1007\/s10555-014-9532-2 (2014).","journal-title":"Cancer Metastasis Rev"},{"key":"33337_CR20","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/B978-0-12-800092-2.00009-5","volume":"123","author":"V Orian-Rousseau","year":"2014","unstructured":"Orian-Rousseau, V. & Sleeman, J. CD44 is a multidomain signaling platform that integrates extracellular matrix cues with growth factor and cytokine signals. Adv Cancer Res 123, 231\u2013254, https:\/\/doi.org\/10.1016\/B978-0-12-800092-2.00009-5 (2014).","journal-title":"Adv Cancer Res"},{"key":"33337_CR21","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1016\/j.joca.2008.12.007","volume":"17","author":"RA Andhare","year":"2009","unstructured":"Andhare, R. A., Takahashi, N., Knudson, W. & Knudson, C. B. Hyaluronan promotes the chondrocyte response to BMP-7. Osteoarthritis Cartilage 17, 906\u2013916, https:\/\/doi.org\/10.1016\/j.joca.2008.12.007 (2009).","journal-title":"Osteoarthritis Cartilage"},{"key":"33337_CR22","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1016\/S0959-8049(96)00512-6","volume":"33","author":"A Dietrich","year":"1997","unstructured":"Dietrich, A., Tanczos, E., Vanscheidt, W., Schopf, E. & Simon, J. C. High CD44 surface expression on primary tumours of malignant melanoma correlates with increased metastatic risk and reduced survival. Eur J Cancer 33, 926\u2013930 (1997).","journal-title":"Eur J Cancer"},{"key":"33337_CR23","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-13-181","volume":"13","author":"H Siiskonen","year":"2013","unstructured":"Siiskonen, H., Poukka, M., Tyynela-Korhonen, K., Sironen, R. & Pasonen-Seppanen, S. Inverse expression of hyaluronidase 2 and hyaluronan synthases 1-3 is associated with reduced hyaluronan content in malignant cutaneous melanoma. BMC Cancer 13, 181, https:\/\/doi.org\/10.1186\/1471-2407-13-181 (2013).","journal-title":"BMC Cancer"},{"key":"33337_CR24","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/j.semcancer.2008.03.005","volume":"18","author":"RH Tammi","year":"2008","unstructured":"Tammi, R. H. et al. Hyaluronan in human tumors: pathobiological and prognostic messages from cell-associated and stromal hyaluronan. Semin Cancer Biol 18, 288\u2013295, https:\/\/doi.org\/10.1016\/j.semcancer.2008.03.005 (2008).","journal-title":"Semin Cancer Biol"},{"key":"33337_CR25","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1038\/jid.2011.325","volume":"132","author":"A Willenberg","year":"2012","unstructured":"Willenberg, A., Saalbach, A., Simon, J. C. & Anderegg, U. Melanoma cells control HA synthesis in peritumoral fibroblasts via PDGF-AA and PDGF-CC: impact on melanoma cell proliferation. J Invest Dermatol 132, 385\u2013393, https:\/\/doi.org\/10.1038\/jid.2011.325 (2012).","journal-title":"J Invest Dermatol"},{"key":"33337_CR26","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1046\/j.1523-1747.2001.00236.x","volume":"116","author":"T Ahrens","year":"2001","unstructured":"Ahrens, T. et al. CD44 is the principal mediator of hyaluronic-acid-induced melanoma cell proliferation. J Invest Dermatol 116, 93\u2013101, https:\/\/doi.org\/10.1046\/j.1523-1747.2001.00236.x (2001).","journal-title":"J Invest Dermatol"},{"key":"33337_CR27","first-page":"295","volume":"2","author":"ME Mummert","year":"2003","unstructured":"Mummert, M. E., Mummert, D. I., Ellinger, L. & Takashima, A. Functional roles of hyaluronan in B16-F10 melanoma growth and experimental metastasis in mice. Mol Cancer Ther 2, 295\u2013300 (2003).","journal-title":"Mol Cancer Ther"},{"key":"33337_CR28","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1046\/j.1523-1747.1999.00804.x","volume":"113","author":"T Ichikawa","year":"1999","unstructured":"Ichikawa, T. et al. Increased synthesis of hyaluronate enhances motility of human melanoma cells. J Invest Dermatol 113, 935\u2013939, https:\/\/doi.org\/10.1046\/j.1523-1747.1999.00804.x (1999).","journal-title":"J Invest Dermatol"},{"key":"33337_CR29","doi-asserted-by":"publisher","first-page":"22513","DOI":"10.1074\/jbc.M708319200","volume":"283","author":"Y Kim","year":"2008","unstructured":"Kim, Y. et al. CD44-epidermal growth factor receptor interaction mediates hyaluronic acid-promoted cell motility by activating protein kinase C signaling involving Akt, Rac1, Phox, reactive oxygen species, focal adhesion kinase, and MMP-2. J Biol Chem 283, 22513\u201322528, https:\/\/doi.org\/10.1074\/jbc.M708319200 (2008).","journal-title":"J Biol Chem"},{"key":"33337_CR30","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1002\/jcb.21925","volume":"105","author":"K Monz","year":"2008","unstructured":"Monz, K. et al. Inhibition of hyaluronan export attenuates cell migration and metastasis of human melanoma. J Cell Biochem 105, 1260\u20131266, https:\/\/doi.org\/10.1002\/jcb.21925 (2008).","journal-title":"J Cell Biochem"},{"key":"33337_CR31","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1016\/j.bbrc.2004.07.041","volume":"321","author":"D Kudo","year":"2004","unstructured":"Kudo, D. et al. Effect of a hyaluronan synthase suppressor, 4-methylumbelliferone, on B16F-10 melanoma cell adhesion and locomotion. Biochem Biophys Res Commun 321, 783\u2013787, https:\/\/doi.org\/10.1016\/j.bbrc.2004.07.041 (2004).","journal-title":"Biochem Biophys Res Commun"},{"key":"33337_CR32","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1139\/bcb-2015-0150","volume":"94","author":"JM Krachulec","year":"2016","unstructured":"Krachulec, J. M., Sedlmeier, G., Thiele, W. & Sleeman, J. P. Footprintless disruption of prosurvival genes in aneuploid cancer cells using CRISPR\/Cas9 technology. Biochem Cell Biol 94, 289\u2013296, https:\/\/doi.org\/10.1139\/bcb-2015-0150 (2016).","journal-title":"Biochem Cell Biol"},{"key":"33337_CR33","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1002\/art.38388","volume":"66","author":"N Luo","year":"2014","unstructured":"Luo, N., Knudson, W., Askew, E. B., Veluci, R. & Knudson, C. B. CD44 and hyaluronan promote the bone morphogenetic protein 7 signaling response in murine chondrocytes. Arthritis Rheumatol 66, 1547\u20131558, https:\/\/doi.org\/10.1002\/art.38388 (2014).","journal-title":"Arthritis Rheumatol"},{"key":"33337_CR34","doi-asserted-by":"publisher","first-page":"1914","DOI":"10.1016\/j.yexcr.2009.03.002","volume":"315","author":"A Kultti","year":"2009","unstructured":"Kultti, A. et al. 4-Methylumbelliferone inhibits hyaluronan synthesis by depletion of cellular UDP-glucuronic acid and downregulation of hyaluronan synthase 2 and 3. Exp Cell Res 315, 1914\u20131923, https:\/\/doi.org\/10.1016\/j.yexcr.2009.03.002 (2009).","journal-title":"Exp Cell Res"},{"key":"33337_CR35","doi-asserted-by":"publisher","first-page":"pl1","DOI":"10.1126\/scisignal.2004088","volume":"6","author":"J Gao","year":"2013","unstructured":"Gao, J. et al. Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci Signal 6, pl1, https:\/\/doi.org\/10.1126\/scisignal.2004088 (2013).","journal-title":"Sci Signal"},{"key":"33337_CR36","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","volume":"2","author":"E Cerami","year":"2012","unstructured":"Cerami, E. et al. The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov 2, 401\u2013404, https:\/\/doi.org\/10.1158\/2159-8290.CD-12-0095 (2012).","journal-title":"Cancer Discov"},{"key":"33337_CR37","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1083\/jcb.150.5.1071","volume":"150","author":"LS Sherman","year":"2000","unstructured":"Sherman, L. S., Rizvi, T. A., Karyala, S. & Ratner, N. CD44 enhances neuregulin signaling by Schwann cells. J Cell Biol 150, 1071\u20131084 (2000).","journal-title":"J Cell Biol"},{"key":"33337_CR38","doi-asserted-by":"publisher","first-page":"39703","DOI":"10.1074\/jbc.M204320200","volume":"277","author":"LY Bourguignon","year":"2002","unstructured":"Bourguignon, L. Y., Singleton, P. A., Zhu, H. & Zhou, B. Hyaluronan promotes signaling interaction between CD44 and the transforming growth factor beta receptor I in metastatic breast tumor cells. J Biol Chem 277, 39703\u201339712, https:\/\/doi.org\/10.1074\/jbc.M204320200 (2002).","journal-title":"J Biol Chem"},{"key":"33337_CR39","doi-asserted-by":"publisher","first-page":"26512","DOI":"10.1074\/jbc.M605607200","volume":"281","author":"L Li","year":"2006","unstructured":"Li, L., Heldin, C. H. & Heldin, P. Inhibition of platelet-derived growth factor-BB-induced receptor activation and fibroblast migration by hyaluronan activation of CD44. J Biol Chem 281, 26512\u201326519, https:\/\/doi.org\/10.1074\/jbc.M605607200 (2006).","journal-title":"J Biol Chem"},{"key":"33337_CR40","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2013.364","volume":"4","author":"K Fuchs","year":"2013","unstructured":"Fuchs, K. et al. Opposing effects of high- and low-molecular weight hyaluronan on CXCL12-induced CXCR4 signaling depend on CD44. Cell Death Dis 4, e819, https:\/\/doi.org\/10.1038\/cddis.2013.364 (2013).","journal-title":"Cell Death Dis"},{"key":"33337_CR41","doi-asserted-by":"publisher","first-page":"8875","DOI":"10.1074\/jbc.M410882200","volume":"280","author":"S Ghatak","year":"2005","unstructured":"Ghatak, S., Misra, S. & Toole, B. P. Hyaluronan constitutively regulates ErbB2 phosphorylation and signaling complex formation in carcinoma cells. J Biol Chem 280, 8875\u20138883, https:\/\/doi.org\/10.1074\/jbc.M410882200 (2005).","journal-title":"J Biol Chem"},{"key":"33337_CR42","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1038\/modpathol.2012.128","volume":"26","author":"EL Alarmo","year":"2013","unstructured":"Alarmo, E. L. et al. Bone morphogenetic protein 4 expression in multiple normal and tumor tissues reveals its importance beyond development. Mod Pathol 26, 10\u201321, https:\/\/doi.org\/10.1038\/modpathol.2012.128 (2013).","journal-title":"Mod Pathol"},{"key":"33337_CR43","doi-asserted-by":"publisher","first-page":"2597","DOI":"10.1084\/jem.20130275","volume":"210","author":"N Yasmin","year":"2013","unstructured":"Yasmin, N. et al. Identification of bone morphogenetic protein 7 (BMP7) as an instructive factor for human epidermal Langerhans cell differentiation. J Exp Med 210, 2597\u20132610, https:\/\/doi.org\/10.1084\/jem.20130275 (2013).","journal-title":"J Exp Med"},{"key":"33337_CR44","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1046\/j.1365-2796.1997.00175.x","volume":"242","author":"L Juhlin","year":"1997","unstructured":"Juhlin, L. Hyaluronan in skin. J Intern Med 242, 61\u201366 (1997).","journal-title":"J Intern Med"},{"key":"33337_CR45","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1038\/labinvest.2008.55","volume":"88","author":"MY Hsu","year":"2008","unstructured":"Hsu, M. Y. et al. Aggressive melanoma cells escape from BMP7-mediated autocrine growth inhibition through coordinated Noggin upregulation. Lab Invest 88, 842\u2013855, https:\/\/doi.org\/10.1038\/labinvest.2008.55 (2008).","journal-title":"Lab Invest"},{"issue":"14","key":"33337_CR46","doi-asserted-by":"publisher","first-page":"1885","DOI":"10.1038\/sj.onc.1202077","volume":"17","author":"Masashi Kato","year":"1998","unstructured":"Kato, M. et al. Transgenic mouse model for skin malignant melanoma. Oncogene 17, 1885\u20131888 (1998).","journal-title":"Oncogene"}],"updated-by":[{"DOI":"10.1038\/s41598-019-55812-5","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2019,12,11]],"date-time":"2019-12-11T00:00:00Z","timestamp":1576022400000}}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-33337-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-33337-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-33337-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T05:22:57Z","timestamp":1671600177000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-33337-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,8]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["33337"],"URL":"https:\/\/doi.org\/10.1038\/s41598-018-33337-7","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,8]]},"assertion":[{"value":"15 February 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 September 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 October 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 December 2019","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"An amendment to this paper has been published and can be accessed via a link at the top of the paper.","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"14913"}}